THE PROGNOSTIC VALUE OF THE EXPRESSION OF P53 IN SQUAMOUS CELL CERVICAL CARCINOMA
DOI:
https://doi.org/10.5281/zenodo.13888634Abstract
The actuality of the topic is due to the high prevalence of cervical cancer, its diagnosis mainly at latestages and unsatisfactory treatment results, which requires improvement of screening methods and treatment of patients with this form of the disease.
References
Higuchi K.H. Flow cytometric and p53 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy // Anticancer Res. — 2021. — Vol. 21, N 4A. — P. 2511–2518.
Horn L.C., Fischer U., Hanel C. et al. P53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread // Pathol. Res. Pract. — 2020. — Vol. 197, N 9. — P. 605–609.
Kleinbaum D.G., Klein M. Survival analysis. A self learning text. — Springer-Verlag, 2015. — 590 p.
Rajaram S., Gupta G., Agarwal S. High-risk human papillomavirus, tumor suppressor protein p53 and mitomycin-C in invasive squamous cell carcinoma cervix // Indian J. Cancer. — 2016. — Vol. 243, N 4. — P. 156–162.
Zhao M., Kim Y.T., Yoon B.S. et al. Expression profiling of p53 in cervical carcinoma // Exp. Oncol. — 2019. — Vol. 28, N 1. — P. 44–48
